Skip to main content

Table 2 Analysis of delta3-transcript expression by fragment analysis, allele specific PCR on c.26 G>A heterozygous samples and competitive quantitative C-QPCR

From: An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predisposition

 

Fragment analysis

% delta3-transcript

/total transcripts

(± standard deviation)

Allelic discrimination

Exclusively on exon3 full-length transcript

(± standard deviation)

Competitive QPCR

% delta3-transcript

/full-length transcript

(± standard deviation)

  

A allele

B allele

 

Wild-type (10 samples)

8 ± 2% *

48 ± 4%A

52%G

4 ± 2%

c.316+3delA

52 ± 7%#

0% A

100%G**

44 ± 4%

Delta3 BRCA2 rearrangement

61 ± 3%#

-

-

44 ± 7%

Intron 2 variants

    

c.68-7T>A

14 ± 2%#

-

-

31 ± 10%

c.68-7T>A

23 ± 4%#

-

-

25 ± 4%

c.68-7T>A

52 ± 2%

27 ± 6%A

73%G

23 ± 3%

c.68-7T>A

45 ± 12%

33 ± 3%A

67%G

27 ± 3%

c.68-7delT

22 ± 2%#

28 ± 2%A

72%G

32 ± 5%

c.68-7_8delinsAA

49 ± 1%

72 ± 10%A

28%G

25 ± 2%

Missense mutations

    

c.125>G, p.Tyr42Cys

6 ± 1%

47 ± 7%A**

53%G**

3 ± 1%

c.223G>C, p.Ala75Pro

3 ± 1%

50 ± 1%G**

50%C**

5 ± 2%

Nonsense mutations

    

c.71T>A, p.Leu24X

5 ± 1%

52 ± 2%T**

48%A**

2 ± 1%

c.244A>T, p.Lys82X

11 ± 1%

52 ± 4%A**

48%T**

11 ± 2%

c.250C>T, p.Gln84X

12 ± 1%

57 ± 4%C**

43%T**

10 ± 6%

  1. # RNA from PAXgene, *three RNA samples from PAXgene and seven RNA samples from lymphoblastoid cells, ** heterozygosity was proven with other set of primer. Values (%) are means of three experiments.